P
Polaris Biology
Polaris Biology is a startup company based in Shanghai, China. Our initiative is focused on single cell-based diagnostics for oncology
About Polaris Biology
Polaris Biology specializes in advanced cancer diagnostics through the analysis of circulating tumor cells (CTCs). Operating in the biotechnology sector, the company serves healthcare providers, research institutions, and pharmaceutical companies. Polaris Biology's core service involves the detection and characterization of CTCs, which are cancer cells that have detached from the primary tumor and circulate in the bloodstream. This technology enables early cancer detection and personalized treatment plans, improving patient outcomes. The business model is primarily B2B, generating revenue through service contracts, diagnostic tests, and collaborative research agreements. Polaris Biology's market includes oncology clinics, hospitals, and research labs focused on cancer treatment and research. The company leverages proprietary technology and expertise in cell biology to offer precise and reliable diagnostic solutions.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jun 2020 | $10M | $40M | Wuxi Capital · Ascendin Fund · 5Y Capital · Delian Capital | — |
| SERIES A✓Equity / VC | Sep 2019 | — | — | Baidu Ventures | — |
Growth signals
Latest recorded traffic for Polaris Biology is 760 monthly website visits, up 985.7% over the last three months. Polaris Biology's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Polaris Biology in the Pudong ecosystem
The Polaris Biology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- PCPuhua Capital
Volcanics Venture
Series A7 investors entered at this stage
- EBEmerging Technology Partners Biomedical
5Y CapitalBaidu Ventures
Delian Capital
Wuxi Capital- AFAscendin Fund
ETP Slovakia - Centre for Sustainable Development
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Polaris Biology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Polaris Biology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









